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Objectives. Determine outcome of the 2005 appropriateness use criteria (AUC) for SPECT in a diverse population of patients
and physicians. Background. AUC for SPECT were the ﬁrst cardiology document to identify 52 clinical indications for imaging,
49 of them for stress SPECT. AUC have been proposed as cornerstone of responsible use of perfusion imaging. Methods. 585
consecutive patients undergoing SPECT were evaluated prospectively. Appropriateness was examined for demographic variables,
clinical variables, and for physician and patient subgroups. Combined end-point of total mortality, cardiac revascularization,
and cardiac admissions at 1 year post SPECT was evaluated. Results. SPECT indications were: appropriate, 63%; uncertain,
20%; inappropriate, 14%; not assigned, 3%. Most appropriate SPECT were observed in patients with known coronary disease
(72%), chest pain syndrome (89%), high pre-test likelihood of disease (100%), men (70%), inpatients (72%), and cardiovascular
physicians’ referrals (69%). End-point was reached in 53 patients (97.4% follow up). Unadjusted event rates were: appropriate
(12%), uncertain (7.1%), inappropriate (2.4%) SPECT (P = .01). Conclusion. Appropriateness of SPECT diﬀers in subgroups of
patients and physicians. Clinically signiﬁcant outcomes occur more frequently in the appropriate stress SPECT group. Focused
eﬀorts are need for outpatients, asymptomatic patients, women, and non-cardiovascular physicians.
1.Introduction
There has been an explosive growth in cardiovascular imag-
ing with stress testing demonstrating 6.1% annual increase
versus 2% for cardiac catheterization, 0.8% for percutaneous
intervention, and 0.1% for acute myocardial infarctions in
population-based study of the United States Medicare pati-
ents from 1993 to 2001 [1]. Increased use of cardiac imaging
has been under scrutiny with the Center for Medicare and
Medicaid Services, and signiﬁcant cuts to SPECT payment
scheduleswereimplementedundertheDeﬁcitReductionAct
inNovember2009.Additionally,insurancepayerscontracted
with radiation services beneﬁt managers to oversee utiliza-
tion of cardiac imaging further limiting access to imaging.
In response to these developments, the American Col-
lege of Cardiology pioneered appropriateness criteria for
single-photon emission computed tomography (SPECT)
myocardial perfusion imaging (MPI) in 2005. The criteria
weredevelopedtoaccountforevidence-basedclinicalreleva-
nce of stress perfusion imaging and were the ﬁrst cardiology-
speciﬁc document to address appropriateness. The criteria
relied on the modiﬁed RAND/UCLA methodology to iden-
tify 52 common clinical scenarios that were divided by level
of appropriateness into appropriate, uncertain, and inappro-
priate indications [2, 3]. 49 indications addressed stress
SPECT, 1 viability, and 2 radiocineangiography. Appropri-
ateness criteria were subsequently developed for stress echo-
cardiography, cardiac computed tomography, cardiac mag-
netic resonance imaging, and coronary revascularization
[4–6]. SPECT criteria were reviewed in 2007 with new desi-
gnations suggested for some indications [7]. An update on
appropriateness criteria was published in May 2009 [8].2 ISRN Cardiology
Appropriateness criteria became incorporated as a mandato-
ry requirement by the Intersocietal Commission of Accre-
ditation of Nuclear Laboratories starting in 2010. The Ame-
rican Recovery and Reinvestment Act of 2009 has endorsed a
concept of comparative eﬀectiveness that needs to be applied
to cardiac imaging, and appropriateness criteria are expected
to play a central role in that process [9]. In September
of 2010, Center for Medicaid and Medicare Services has
solicited an evaluation of point-of-order and point-of ser-
vice determination of appropriateness in Medicare beneﬁ-
ciaries across a broad range of physicians and settings:
SPECTMPIwastheonlycardiacprocedureincluded.(http://
www.cms.gov/DemoProjectsEvalRpts/downloads/Medicare
Imaging Demonstration.pdf). To encourage the best use of
AUC and decrease inappropriate imaging, the ACC national
quality initiative Imaging in “Focus” (http://www.cardix-
osource.org/Science-And-Quality/Quality-Programs/Imagi-
ng-in-FOCUS.asp) contains multiple resources pertaining to
the AUC, including a decision algorithm has been developed
by the ACC in partnership with Skyscape [10]. A free
smartphone AUC application based on 2009 guidelines has
been released (http://www.astellasapps.com/).
Despite these developments, the clinical use of the
appropriateness criteria has not become standard of practice
for physicians. Gibbons et al. have investigated performance
of appropriateness criteria for stress SPECT and stress
echocardiography in 284 and 298 patients, respectively [11].
Overall, 64% of stress studies were appropriate. 14% of
SPECT and 18% of stress echocardiography studies were
performed for inappropriate indications, and approximately
10% of all patients were unclassiﬁable. In a prospective
multicenter trial, the appropriateness criteria were evaluated
in 7 physician practices of various size in partnership
with United HealthCare. Overall, 14% of all studies were
inappropriate, most in asymptomatic individuals [12].
The objectives of the current study were to identify
clinical value of 2005 AUC in various patient and physician
groups and to focus on downstream use of resources as
deﬁned by patient outcomes in relation to appropriateness.
We have prospectively applied appropriateness criteria to a
diverse population of patients and physicians to evaluate:
(1) impact of demographic (gender) and clinical (known
coronary disease, symptoms, pretest likelihood,
Framinghamriskscores(FRS),andadmissionstatus)
factors,
(2) impact of referring physician specialty and practice
type,
(3) outcomes at 1 year after SPECT (combined end-
point of total mortality, coronary revascularization,
or admission for cardiac reason other than revascu-
larization).
2. Methods
2.1. Patient Population. Over 3,000 patients undergo SPECT
at our institution annually. From March 2007 thorough
April 2008, consecutive patients older than 18yrs of age
were enrolled if they were English speaking, had a capacity
for primary decision making, had no chronic illnesses or
malignancy with estimated life expectancy of less than 1
year, and were willing to provide informed consent for access
to their medical record, phone call followup and/or social
security number. The ﬁnal cohort consisted of 585 patients.
Admission status was ascertained at the time of SPECT
as inpatient or outpatient based on registration record.
Reason for stress, type of stress, known cardiac history
(deﬁned as prior myocardial infarction or revascularization),
risk factor proﬁle, and name of the referring physician
were obtained and recorded. Followup was complete in 554
patients (94.7%).
2.2. Physician Specialty Veriﬁcation. Referring physician
name for each patient was cross-referenced with the hospital
roster of credentialed physicians for both voluntary and full-
time faculty. All cardiology and cardiac surgery physicians
were designated as cardiovascular (CV MD). All other
physicians were designated as noncardiovascular (non-CV
MD). There were 258 patients referred by CV MDs, and 327
referred by non-CV MDs.
2.3. Appropriateness Criteria. Appropriateness criteria tables
wereincludedineachpatient’sﬁleuponrecruitmentintothe
study [3, 13]. Appropriateness was determined prospectively
based on symptoms, pre-test likelihood of disease [14],
Framingham risk scores, FRS [15], and presence or absence
of 49 stress SPECT MPI indications as identiﬁed during
patient interview. While pre-test likelihood of disease was
determined for all patients, FRS were estimated for asymp-
tomaticpatientswithoutknowncoronaryarterydisease.The
following assumptions were made.
(1) Lipid values were often not available for calculation
of FRS. Total cholesterol and HDL cholesterol were
assigned 0 points if no dyslipidemia or treatment
with statins were reported, and 1 point if reported.
(2) Any chest pain syndrome or anginal equivalent were
recognized as symptoms.
(3) If more than one indication was identiﬁed, the most
appropriate for SPECT was chosen by consensus
opinion of investigators.
2.4. Statistical Analysis. Chi-square was used, and Fisher
exact test was substituted for chi-square as indicated by
frequencies of observations. SAS 9.1 (Cary, NC) was used for
analysis.
3. Results
3.1. Patient Population. Patient characteristics are presented
in Table 1. Overall, 570 (97%) of patients were assigned by
appropriateness indications. Among 15 (3%) patients not
classiﬁable 3 were inpatients, 12 were outpatients, 12 were
men, 3 were women, 8 had known CAD, and 7 had no CAD.
7 unassigned patients were asymptomatic: 2 with a low FRS,
and 5 with an intermediate FRS.
Two site-speciﬁc patterns of care are important to
mention. Our emergency room policy expedites admissionISRN Cardiology 3
Table 1: Patient population.
Patient characteristics N;%
Age (mean ± SD) 63.5 ±13.1yrs
Admission status
Inpatient 268; 48%
Outpatient 317; 54%
Gender
Men 307; 55%
Women 266; 45%
Known CAD
Yes 166; 28%
No 419; 72%
Symptoms
Yes 307; 53%
No 278; 47%
Pretest likelihood
Low 299; 51%
Intermediate 253; 43%
High 33; 6%
Framingham risk
Low 58; 33%
Intermediate 101; 58%
High 16; 9%
Test type
Exercise 335; 57%
Pharmacologic 249; 43%
Uncertain: 116, 20%
Not assigned: 15, 3%
Inappropriate: 84, 14%
Appropriate: 370, 63%
Figure 1: Distribution of studies in each of the appropriateness
categories. Appropriate (green), uncertain (gold), inappropriate
(red), not assigned (purple). Numbers of patients in each category
and percent of all patients (rounded to the nearest whole value) are
shown next to the corresponding symbols.
to the in-house hospitalist service for any patient with a “soft
rule out MI”, thus many of them were inpatients at the time
of SPECT MPI. Additionally, despite a rather high number
of patients with symptoms (53%), only 6% of patients were
in the high pre-test category reﬂecting a bias toward invasive
coronary angiography.
3.2. Indications for SPECT. 570 (97%) patients were clas-
siﬁed by clinical indications with 15 (3%) not assigned
(Figure 1). Most commonly observed indications in our
patient population are listed below by category (% of all
patients). Additional indications were observed in ≤1% of
the patients.
3.2.1. Appropriate Indications. Of all stress SPECT studies,
63% were appropriate with the most common indications as
follows:
(1) detection of CAD, symptomatic: 37%
(i) intermediate pre-test probability, ECG inter-
pretable and able to exercise: 21%; ECG unin-
terpretable or unable to exercise: 12%,
(ii) highpre-testprobability,ECGinterpretableand
able to exercise: 3%; ECG uninterpretable or
unable to exercise: 2%,
(2) Risk assessment: 23%
(i) after revascularization (PCI or CABG): 12%
(a) symptomatic,evaluationofchestpain:7%,
(b) asymptomatic prior to CABG, ≥ 5yrsafter
CABG: 3%; symptomatic prior to CABG,
≥5yrs,3%,
(ii) preoperative evaluation for noncardiac surgery
intermediate risk predictor or poor exercise
tolerance (<4METS): 4%,
(iii) with prior test results: 4%
(a) asymptomatic or stable symptoms, abnor-
mal catheterization or prior SPECT ≥2yrs
to evaluate worsening disease: 2%,
(iv) high FRS, asymptomatic: 3%,
3.2.2. Uncertain Indications. Uncertain indications for
SPECT were observed in 20%. The most common uncertain
indications were.
(1) detection of CAD: asymptomatic, moderate FRS:
15%,
(2) risk assessment: 5%
(i) after revascularization, symptomatic prior to
revascularization ≥2yrs after PCI: 4%; asymp-
tomatic, ≥2yrsafterPCI:1%.
3.2.3. Inappropriate Indications. Inappropriate indications
were observed in 14%
(1) detection of CAD: 13%
(i) asymptomatic, low FRS: 7%,
(ii) symptomatic, ECG interpretable and able to
exercise: 6%,
(2) risk assessment: 1%
(i) Preoperative evaluation prior to non-cardiac
surgery, minor to intermediate risk predictor,
normal exercise tolerance (>4METS): 1%.
There were 15 (3%) unclassiﬁable patients. The observed
indications were: syncope [1], intermediate Duke treadmill4 ISRN Cardiology
Table 2: SPECT MPI indications observed in the study: comparison of 2005 and 2009 AUC.
Indications 2005 2009
Detection of CAD:
(i) symptomatic, intermediate or high pretest probability, A A
(ii) asymptomatic, moderate Framingham Risk Score (FRS)∗, U E C Gi n t e r p r e t :I ,n o t :U
(iii) asymptomatic, high FRS, A A
(iv) asymptomatic, low FRS or symptomatic, ECG interpretable
and able to exercise, II
After revascularization (PCI or CABG):
(i) symptomatic, A A
(ii) asymptomatic or symptomatic prior to CABG, ≥5yrsafter †,A A
(iii) asymptomatic or symptomatic prior to PCI, ≥2yrsafter . U U
Prior test results:
(i) asymptomatic or stable symptoms, abnormal catheterization
or prior SPECT ≥2yrs to evaluate worsening disease AU
Preoperative evaluation prior to intermediate-high risk
noncardiac surgery:
(i) clinical risk factors and poor exercise tolerance (<4MET s), A A
(ii) no or minor risk factors, normal exercise tolerance
(≥4MET s). II
Unclassiﬁed indications:
(i) syncope, — Low risk: I, int-high: A
(ii) intermediate Duke treadmill score, low FRS, — —
(iii) new onset atrial ﬁbrillation, moderate FRS, — U
(iv) asymptomatic, prior myocardial infarct of unknown age, — U
(v) symptoms unknown before PCI < 2y r sa g o , — —
(vi) known CAD; failed PCI, — U
(vii) normal SPECT MPI >2y r sa g o ,m o d e r a t eF R S . — U
∗ATP III in 2009 AUC. †No symptoms prior to revascularization in 2009 AUC.
score, low FRS [1], new onset atrial ﬁbrillation, moderate
FRS[2],asymptomatic,priormyocardialinfarctofunknown
age [2], symptoms unknown before prior PCI less than 2yrs
[3], known CAD, failed PCI [2], normal myocardial perfu-
sion imaging more than 2yrs ago, and moderate FRS [4].
While most of the appropriate, uncertain, and inappro-
priate indications observed in our patients were similar for
2005 and 2009 AUC, most of the unassigned patients were
categorized as uncertain by 2009 AUC as shown in Table 2.
3.2.4. Appropriateness of SPECT by Symptoms and Pretest
Likelihood. As expected, symptoms (Figure 2(a))a n dp r e -
test likelihood of disease (Figure 2(b)) signiﬁcantly aﬀected
SPECT appropriateness. Appropriate studies were observed
in88%ofpatientswithsymptoms,in96%ofanintermediate
pre-test likelihood group, and in 100% of a high pre-
test likelihood group. Most of the inappropriate SPECT
were observed in asymptomatic and low pre-test likelihood
patients (58/84 and 83/84, resp.). Most of the uncertain
stress SPECT were also observed in asymptomatic and low
likelihood patients (106/116 and 107/116, resp.). Pretest
likelihood did not diﬀer by gender or known CAD.
3.3. Appropriateness of SPECT in Asymptomatic Patients.
Asymptomatic patients without CAD were analyzed for
stress SPECT appropriateness using FRS (Figure 3). Of the
175 patients, 7 were not assigned by appropriateness criteria.
In the remaining group of 168 patients, FRS were low in
56 (33%), intermediate in 96 (57%), and high in 16 (9%).
Based on age and gender, 160 had low pre-test probability
of disease, and 8 were in the intermediate probability group.
Most high FRS patients had appropriate SPECT (88%),
thosewithanintermediateFRShadmostlyuncertainSPECT
(74%),whilepatientswithlowFRShadmostlyinappropriate
SPECT (88%).
3.4. Appropriateness by Admission Status, Gender, and Known
CAD. Admissionstatus,gender,andknownCADinﬂuenced
SPECT appropriateness (Table 3).
3.4.1. Admission Status. In comparison to outpatients, inpa-
tients were more symptomatic (65% versus 43%, P<
.0001), and at a higher pre-test likelihood risk (low: 44%
versus 57%, intermediate/high: 56% versus 43%, P = .02)
but did not diﬀer by gender, known CAD, or FRS. MostISRN Cardiology 5
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Figure 2: Appropriateness of SPECT by (a) symptoms and (b) pretest likelihood of disease ((a), (b): P<. 0001). Symptoms refer to chest
pain or anginal equivalent. Pretest likelihood: low, intermediate, or high based on age, gender, and symptoms. A, appropriate (green); U,
uncertain (gold); I, inappropriate (red). Number of patients is shown next to the corresponding symbols for each of the appropriateness
designations. Percent within each category is reﬂected on the horizontal axis.
Table 3: SPECT appropriateness by admission status, gender and known CAD.
Patient Variables Appropriate Uncertain Inappropriate P Value
N,% N,% N,%
Admission
Inpatient (n = 256) 184; 72% 33; 13% 39; 15% .0004
Outpatient (n = 305) 179; 59% 83; 27% 43; 14%
Gender
Men (n = 307) 214; 70% 66; 21% 27; 9% <.0001
Women (n = 263) 156; 59% 50; 19% 57; 22%
Known CAD
Yes (n = 158) 117; 74% 34; 22% 7; 4% <.0001
No (n = 412) 253; 61% 82; 20% 77; 19%
inpatients (66%) were referred by non-CV MDs (Table 2).
Most inpatients had appropriate stress SPECT studies (72%)
with inappropriate SPECT similar to outpatients (15% and
14%, resp.). More uncertain SPECT (27% versus 13%) was
observed in outpatients.
3.4.2. Gender. Women had more symptoms (57% versus
49%, P = .04), and less known CAD (15% versus 39%,
P<. 0001) but did not diﬀer in pre-test likelihood categories
as compared with men. FRS were diﬀerent for asymptomatic
women as compared to men with more women in the low,
and fewer women in the high risk groups: low, 41% versus
24; intermediate, 54% versus 61%; high, and 5% versus 15%,
P = .01. Most women were referred by non-CV MDs (66%)
with more even distribution among specialty of physicians
for men (Table 2). As compared to men, women had less of
appropriate SPECT (59% versus 70%) with nearly a three-
fold diﬀerence in inappropriate SPECT (22% versus 9%).
3.4.3. Known CAD. Compared to patients without known
CAD, patients with CAD had fewer symptoms (42% versus
58%, P = .0007). More men (39%) than women (15%) had
known CAD (P<. 0001). 72% of all known CAD patients
were referred by CV MDs. Patients with known CAD had
more appropriate SPECT (74% versus 61%), and the least of
inappropriate SPECT (4% versus 19%, P<. 0001).
3.5. Appropriateness by Physician Specialty. There were dif-
ferences in admission status, gender, and known CAD
by referring physician specialty (Table 4). Most inpatients
(66%) were referred by non-CV MDs. As expected, the
majority of patients with known CAD were referred by CV
MDs (72%). More men than women were evaluated by CV
MDs. CV MDs outperformed non-CV MDs (Table 5)w i t h
more appropriate, and less inappropriate SPECT referred
(69% versus 62%, and 10% versus 18%, resp., P = .03).
Among CV MDs, private practitioners had a trend for more6 ISRN Cardiology
High Framingham risk
Intermediate Framingham risk
Low Framingham risk
0 1 02 03 04 05 06 07 08 09 0 1 0 0
(%)
A, 4 I, 49 U, 3
A, 22 I, 3 U, 71
A, 14 U, 2
Figure 3: Appropriateness of SPECT in asymptomatic patients without known CAD stratiﬁed by Framingham risk scores (P<. 0001). A,
appropriate (green); U, uncertain (gold); I, inappropriate (red). Number of patients is shown next to the corresponding symbols for each of
the appropriateness designations. Percent within each category of Framingham risk is reﬂected on the horizontal axis.
appropriate SPECT than full-time faculty cardiologists (74%
versus 63%) although this diﬀerence was not signiﬁcant. As
described above, more women and inpatients were referred
by non-CV MDs while more men, outpatients, and patients
with known CAD were referred by CV MDs.
3.6. Outcome Analysis by Appropriateness Category. Follow
up was completed in 554 patients: 359 with appropriate,
113 with uncertain, and 82 with inappropriate SPECT.
Combined end-point of total mortality, revascularization
and hospital admission for a cardiac reason other than revas-
cularization was reached in 53 patients. There were 20 death
(17 in appropriate SPECT patients), 14 revascularizations
(13inappropriateSPECTpatients),and28admissions(21in
appropriate SPECT patients). Unadjusted events rates were
12% (43 of 359 patients) for appropriate, 7.1% (8 of 113
patients) for uncertain, and 2.4% (2 out of 82 patients) for
inappropriate SPECT (P = .01).
4. Discussion
This study prospectively evaluated 2005 SPECT appropriate-
ness criteria in a diverse patient and physician population
from a large regional medical center. Overall, prevalence
of appropriate (63%) and inappropriate (14%) SPECT was
similar to those reported by previous studies [11]. The
patient population was diverse: nearly equally representative
of men and women, patients with or without CAD, inpa-
tients and outpatients, and referred by private as well as full-
time faculty cardiologists and noncardiologists. Almost all
patients were successfully assigned into an appropriateness
category with only 3% not classiﬁable (Figure 1). Followup
was complete in 97.4% of patients, and outcome analysis
was undertaken for a combined end point of total mortality,
cardiac revascularization, and cardiac admission for reason
other than revascularization.
Several important conclusions emerge from this study.
First, appropriateness of SPECT was strongly inﬂuenced
by presence of symptoms (Figure 2(a)), pre-test likeli-
hood of disease (Figure 2(b)), and Framingham risk scores
(Figure 3). As may have been expected, there was a strong
trend for more appropriate studies in symptomatic patients
and those at a greater likelihood of CAD. Importantly, most
inappropriate studies were observed in asymptomatic and
low risk patients. These ﬁndings prove the robustness of
criteria in clinical application. While speciﬁc scenarios may
diﬀer from institution to institution, the recognition of these
generalpatternsinappropriatenesscriteriashouldbehelpful
to clinicians.
Secondly, ﬁndings emerged in patient subgroups that
are interesting and require further investigation. As may be
expected, inpatients were more symptomatic and at a higher
clinical probability of coronary artery disease. Thus, it is
not surprising that more appropriate SPECT studies were
observed in inpatients. Appropriateness criteria appeared
more favorable toward patients with established CAD.
Women were more symptomatic than men but did not
diﬀer in pre-test likelihood of disease and had a lower
prevalence of known CAD. Among asymptomatic patients,
more women were at a lower FRS. While less of appropriate
SPECT was observed for women (59% versus 70% in men,
Table 3), the most notable diﬀerence was in the occurrence
of the inappropriate studies (22% in women versus 9% in
men). It is likely that such a diﬀerence cannot be attributed
solely to less prevalent CAD or lower FRS. These ﬁndings
suggest a gender-related referral bias and indicate that it may
beimportanttoincludegender-speciﬁcrecommendationsin
the appropriateness criteria.
Another challenging group were asymptomatic patients
in an intermediate FRS group (Figure 3). Most of them
had uncertain SPECT (74%), some were appropriate (23%),
and very few were inappropriate (3%). Performing SPECT
in asymptomatic patients may not be warranted, and
further studies are needed to determine merits of SPECT
imaging in this patient subgroup. The 2009 AUC consider
intermediate risk patients with interpretable ECG in theISRN Cardiology 7
Table 4: Diﬀerences by gender, admission status, and known history of CAD by specialty of a referring physician.
Patient Variables CV MD NON- CV MD P Value
N,% N,%
Admission
Inpatient (n = 265) 90; 34% 175; 66% <.0001
Outpatient (n = 305) 159; 52% 146; 48%
Gender
Men (n = 307) 159; 52% 148; 48% <.0001
Women (n = 263) 90; 34% 173; 66%
Known CAD
Yes (n=158) 113; 72% 45; 28% <.0001
No (n=412) 136; 33% 276; 67%
CV:cardiovascular.
Table 5: SPECT appropriateness by physician specialty and practice type. Diﬀerences were signiﬁcant for non-CV and CV MDs (P = .03)
but not for full-time versus private CV MDs.
Physicians Appropriate Uncertain Inappropriate
N,% N,% N,%
Non-CV (n = 321) 198; 62% 65; 20% 58; 18%
CV (n = 249) 172; 69% 51; 21% 26; 10%
Private (n = 132) 98; 74% 21; 16% 13; 10%
Full-time faculty (n = 117) 74; 63% 30; 26% 13; 11%
CV: cardiovascular.
inappropriate, and those with uninterpretable ECG in the
uncertain categories. Further discussion of the merits of
SPECT MPI and other modalities in the asymptomatic
patients is provided in the informational statements on
http://asnc.org/imageuploads/Asymptomatic.pdf.
There were notable diﬀerences by referring physician
specialty. Cardiovascular physicians outperformed their
noncardiovascular colleagues with more appropriate SPECT
referred, although that diﬀerence was small (69% versus
62%). Importantly, signiﬁcantly fewer inappropriate studies
were referred by cardiovascular MDs (10% versus 18%,
Table 5). These results may be reﬂective of a patient selection
bias as more “appropriate” patients such as men, and those
withknownCADwerereferredbycardiovascularphysicians.
However, signiﬁcantly more inpatients (another “appropri-
ate” group) were referred by noncardiovascular MDs. No
signiﬁcant diﬀerences were observed among private and
faculty cardiologists. Further educational and consultative
eﬀorts are likely needed to increase appropriateness of
referrals by noncardiovascular physicians.
Finally, outcomes diﬀered signiﬁcantly by appropri-
ateness of SPECT. Unadjusted event rates were high for
patientswithappropriateSPECT(12%),lowerforthosewith
uncertain SPECT (7.1%), and lowest for the inappropriate
SPECT patients (2.4%). A 7.1% event rate in the uncertain
group suggests that it is prudent to perform these studies
until factors or scenarios are identiﬁed that would allow to
further risk stratify this group.
4.1. Limitations. Notable limitations exist in this study.
First, this represented a single medical center experience.
As such, selection bias, referral bias, and practice preference
bias were all present. Second, we have made assumptions
in calculating FRS that may have aﬀected appropriateness
designations. Third, not all appropriateness indications were
equally prevalent in our cohort, and some were observed in
less than 1% of the patients. Fourth, we have not been able to
evaluate cardiac mortality but rather a combined end point
that included total mortality, revascularization, and cardiac
admissions. Fifth, 15 of our patients remained unclassiﬁed.
Most of them would have been assigned as uncertain if 2009
AUC were used, and not likely to aﬀect appropriate and
inappropriate groups.
5. Conclusion
Wehaveestablishedthatappropriatenesscriteriaareeﬀective
in identifying appropriateness of SPECT in a diverse patient
population. More appropriate studies were observed in
patients with symptoms and at higher pre-test likelihood
and Framingham risk. Most of the inappropriate studies
were observed in asymptomatic and low risk patients.
Patients without known CAD, women, and those with
an intermediate Framingham risk emerged as subgroups
where further investigation is warranted. Physician specialty
was an important factor determining appropriateness with8 ISRN Cardiology
cardiovascular physicians outperforming their noncardio-
vascular colleagues. Unadjusted event rates were highest in
the appropriate SPECT group, intermediate in the uncertain
group, and lowest for the inappropriate SPECT patients.
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